Chidamide exerts anti-tumor effects by inducing Mcl-1 degradation via the ubiquitin- proteasome pathway, promoting apoptosis and inhibiting aerobic respiration of pancreatic cancer cells. The gene discussed is MCL1; the disease is pancreatic neoplasm.